Takeda to license Trianni mAb discovery platform
Takeda has entered into a license agreement for the use of the Trianni Mouse, a monoclonal antibody discovery platform.
Takeda has entered into a license agreement for the use of the Trianni Mouse, a monoclonal antibody discovery platform.
Enzyme experts trying to make the anticancer APIs vincristine and vinblastine with engineered cell lines say the technology could be used to produce a wide range of plant-derived drug actives including alkaloids like morphine.
Kyowa Hakko Kirin has completed construction of a ¥6bn ($60m) biomanufacturing plant in Japan boasting a 12,000L stainless steel mammalian bioreactor.
Revising the regulations that govern gene and cell therapies - known as advanced therapy medicinal products (ATMPs) - will increase the number of marketing authorisation applications for such products and attract more Big Pharma involvement according to...